Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $5.20MP/E –Yield –
Processa Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
Processa Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2016 was 100.0%. For fiscal 2016 it was 100.0%, against -11.0% the year before. The highest annual figure on record is 100.0% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | 100.0% | +111.0 |
| FY2015 | Dec 31, 2015 | -11.0% | −48.7 |
| FY2014 | Dec 31, 2014 | 37.7% | −2.2 |
| FY2013 | Dec 31, 2013 | 39.8% | +9.2 |
| FY2012 | Dec 31, 2012 | 30.6% | – |
See a number that looks wrong?